Abstract:Tumors of one or multiple parathyroid glands and elevated serum calcium and parathyroid hormone (PTH) are the common characteristics of primary hyperparathyroidism (PHPT). Genes associated with familial PHPT (hereditary parathyroid tumors) include - MEN1, CDKN1B, CDC73, RET, MAX and GCM2. The glial cells missing 2 (GCM2) gene functions as a transcription factor that is essential for parathyroid gland development. Heterozygous germline missense variants located within the C-terminal conserved inhibitory domain (CCID) of GCM2 have been reported in a subset of patients with familial PHPT. In functional assays, these missense variants enhance the transcriptional activity of GCM2, suggesting that GCM2 could act as a proto-oncogene in parathyroid neoplasia. A recurrent germline activating missense variant of GCM2, p.Y394S in patients with familial PHPT has been reported in various publications. To study the direct contribution of this missense variant in parathyroid neoplasia, we used the CRISPR/Cas9 system to generate a heterozygous germline knock-in of p.Y392S in the mouse Gcm2 gene (which corresponds to the human variant p.Y394S in GCM2). In GCM2-binding site mediated luciferase reporter assays, the mouse Gcm2 variant p.Y392S also exhibited the transcription enhancing effect that was observed for the human GCM2 p.Y394S variant. However, mice with this variant (Gcm2 +/Y392S) did not show obvious parathyroid tumors. Because the mouse Gcm2 variant p.Y392S exhibited enhanced transcriptional activity, we performed spatial transcriptomics of parathyroid glands from wildtype (WT) and Gcm2 +/Y392S mice to examine differentially expressed transcripts in parathyroid cells with the p.Y392S variant of Gcm2. Using the 10X Genomics Visium platform, spatially resolved RNA-seq analysis was performed on parathyroid gland cells of WT and Gcm2 +/Y392S mice specifically marked by the expression of Pth and Gcm2. Spatial transcriptomics and Pathway analysis was performed to evaluate transcripts with more than 2-fold increased expression in parathyroid cells from the p.Y392S variant of Gcm2 compared to WT. Further investigation of these genes and pathways in mouse and human parathyroid cells can provide insights into the functional consequences of GCM2 activating variants and the pathophysiology of parathyroid tumorigenesis. Citation Format: Priyanka Bolel, Jeremie O. Pina, Fabio R. Faucz, Lee S. Weinstein, Sunita K. Agarwal. Spatial transcriptomics of mouse parathyroid gland cells expressing an activating variant of gcm2 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl) nr LB153.

Expression of Gcm2 in secondary hyperparathyroidism rats

Gcm2 Gene Knock-out Induces the Hypoparathyroidism in Adult Mice

RNA-sequence Reveals Differentially Expressed Genes Affecting the Secondary Hyperparathyroidism

Effects Of Fgf-23-Mediated Erk/Mapk Signaling Pathway On Parathyroid Hormone Secretion Of Parathyroid Cells In Rats With Secondary Hyperparathyroidism

A Knock-In Mouse Model of the Gcm2 Variant p.Y392S Develops Normal Parathyroid Glands

Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency

Implications of Regulator of G-protein Signaling 5 Expression in the Pathogenesis of Primary and Secondary Hyperparathyroidism

Abstract LB153: Spatial transcriptomics of mouse parathyroid gland cells expressing an activating variant of gcm2

[Relationship Between Proliferation and Apoptosis of Parathyroid Cell in Rabbits with Primary Hyperparathyroidism].

Identification of key biomarkers based on the proliferation of secondary hyperparathyroidism by bioinformatics analysis and machine learning

Use of 99Mtc-Sestamibi SPECT/CT Imaging in Predicting the Degree of Pathological Hyperplasia of the Parathyroid Gland: Semi-Quantitative Analysis.

Primary and secondary hyperparathyroidism present different expressions of calcium-sensing receptor

Overexpression of Parathyroid Pituitary-Specific Transcription Factor (Pit)-1 in Hyperphosphatemia-Induced Hyperparathyroidism of Chronic Renal Failure Rats

Establishment of Rat Secondary Hyperparathyroidism Model and Effects on Bone Change

Plasma Metabolite Biomarkers Related to Secondary Hyperparathyroidism and Parathyroid Hormone.

The Effect of Parathyroid Hormone on Expression of Matrix GLA Protein in Ovariectomized SD Rats and Primary Osteoblasts

[Effect of Parathyroid Hormone (1-34) on Expression of Matrix Gla Protein and Wnt/β Catenin Signaling Pathways in MG63 Cell Lines].

Expression of the Calcium Receptor CaR in the Parathyroid of Secondary Hyperparathyroidism Patients.

The Study of an Animal Model in Rabbits with the Early Primary Hyperparathyroidism

[Pckm-Mpth Recombinant Plasmid Therapy for Hypoparathyroidism: an in Vivo Experimental Research with Rats].

Expression and role of glioma-associated oncogene 2 in giant cell tumor of bone